Talking With Your Doctor
Being prepared for your next appointment
Before you visit your doctor, it might be helpful to think about what you want to
talk about or the questions you want to ask. To help you organize your thoughts,
CSL Behring has created an Interactive Doctor Discussion Guide that you can use
to prepare for your next appointment.
Personalized Discussion Guide
What questions do you want to ask your doctor?
This interactive tool provides a list of frequently asked questions that patients
have for their physician. Check the questions that you have for your doctor to create
a personalized discussion guide that you can print and take to your appointment.
Create Your Guide
Personalize & Print
Please check-off the questions that you feel are most important to discuss with
your doctor. If you have any other questions you'd like to add to this list, write
them at the bottom in the space provided. When complete, click the PRINT button to generate your personalized discussion
guide. Only the questions you have selected will appear in your guide. Be sure to
bring the guide with you to your next doctor's appointment.
Do I Have Alpha-1?
Important Safety Information
Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira are not available.
Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.
In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).
Zemaira is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.
Please see full prescribing information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.